Hypoproteinemia: Clinical Trials

8 trials for Hypoproteinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 unknown. 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 38Completed 5, Terminated 2, Unknown 1

Follow Hypoproteinemia: new trials by email Literature Review of Hypoproteinemia trials Research Report on Hypoproteinemia

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia
OsrHSA, Plasbumin®-20 - Hypoalbuminemia, Hepatic Cirrhosis
Phase 3CompletedHealthgen Biotechnology Corp.3282023-04-102024-04-09
Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
Albumin Human - Community-acquired Pneumonia, Hypoalbuminemia
Phase 3TerminatedJordi Carratala392019-10-312023-01-31
Albumin for Hepatocellular Carcinoma
Albumin infusion - Hepatocellular Carcinoma, Hypoproteinemia
Phase 3UnknownGuangxi Medical University2002019-03-012020-07-22
Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled Trial
Intravenous albumin, Normal saline - Edema, Hypoproteinemia
Phase 3CompletedHamilton Health Sciences Corporation462014-09-012024-03-25
Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10
CoQ10, Sanomit Placebo - Ataxia-oculomotor Apraxia 1
Phase 3CompletedAssistance Publique - Hôpitaux de Paris192013-06-012017-11-06
Volume Replacement With Albumin in Severe Sepsis
Albumin and Crystalloids, Crystalloids - Severe Sepsis, Septic Shock
Phase 3CompletedFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico18182008-07-012015-11-10
Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
pentoxiphylline, Nepro, anti-inflammatory module (similar to Oxepa) - Hypoalbuminemia, Protein-energy Malnutrition
Phase 3CompletedLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center932008-02-012015-05-21
The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
Thalidomide, Sugar pill - Hypoalbuminemia
Phase 3TerminatedGeorge A. Kaysen, M.D.162007-09-012018-04-02

Narrower conditions

Hypoalbuminemia (6)  ·  Inflammation (3)  ·  Critical Illness (2)  ·  Carcinoma, Hepatocellular (1)  ·  Community-Acquired Pneumonia (1)  ·  Early-onset ataxia with oculomotor apraxia and hypoalbuminemia (1)  ·  Edema (1)  ·  Liver Cirrhosis (1)  ·  Protein-Energy Malnutrition (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sepsis (1)  ·  Shock, Septic (1)

Broader conditions

Blood Protein Disorders (8)  ·  Hematologic Diseases (8)  ·  Hemic and Lymphatic Diseases (8)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Disease Attributes (3)  ·  Digestive System Diseases (2)  ·  Infections (2)  ·  Liver Diseases (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Chronic Disease (1)  ·  Community-Acquired Infections (1)  ·  Deficiency Diseases (1)

Interventions

Albumins (2)  ·  Crystalloid Solutions (1)  ·  Pentoxifylline (1)  ·  Saline Solution (1)  ·  Serum Albumin, Human (1)  ·  Sugars (1)  ·  Thalidomide (1)  ·  coenzyme Q10 (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  George A. Kaysen, M.D. (1)  ·  Guangxi Medical University (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Healthgen Biotechnology Corp. (1)  ·  Jordi Carratala (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)

Countries

China (2)  ·  United States (2)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  Spain (1)

Top investigators

Alexander Rombauts (1)  ·  Antonio Pesenti, MD (1)  ·  Arezu Dezfuli, MD (1)  ·  George A Kaysen, MD Ph.D (1)  ·  Gianni Tognoni, MD (1)  ·  James F. Winchester, MD (1)  ·  Jennie Jing, MS (1)  ·  Kamyar Kalantar-Zadeh, MD MPH PhD (1)  ·  Luciano Gattinoni, MD (1)  ·  Marilena Romero (1)  ·  Perrine Charles, MD, PhD (1)  ·  Pietro Caironi, MD (1)  ·  Roberto Fumagalli, MD (1)  ·  Roberto Latini, MD (1)

Results publications

PMID 20633946, PMID 24635772, PMID 24919684, PMID 26671516, PMID 26847922, PMID 28411114, PMID 29787743, PMID 30261898, PMID 32390133, PMID 32409206, PMID 32585739, PMID 32819439, PMID 33741039, PMID 34825972, PMID 37916745

NIH funding

2018 (1), R21DK078012 (1)